Covid-19 Impact on Global Anti-PD-1 Antibody Market Insights, Forecast to 2026
Anti-PD-1 Antibody is used to inhibit PD-1 and its downstream signaling pathways.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Anti-PD-1 Antibody market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Anti-PD-1 Antibody industry.
Based on our recent survey, we have several different scenarios about the Anti-PD-1 Antibody YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Anti-PD-1 Antibody will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti-PD-1 Antibody market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti-PD-1 Antibody market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Anti-PD-1 Antibody market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Anti-PD-1 Antibody market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Anti-PD-1 Antibody market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Anti-PD-1 Antibody market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti-PD-1 Antibody market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti-PD-1 Antibody market.
The following manufacturers are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Anti-PD-1 Antibody market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Anti-PD-1 Antibody industry.
Based on our recent survey, we have several different scenarios about the Anti-PD-1 Antibody YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Anti-PD-1 Antibody will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti-PD-1 Antibody market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti-PD-1 Antibody market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Anti-PD-1 Antibody market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Anti-PD-1 Antibody market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Anti-PD-1 Antibody market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Anti-PD-1 Antibody market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti-PD-1 Antibody market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti-PD-1 Antibody market.
The following manufacturers are covered in this report:
- Bio X Cell
- Thermo Fisher
- InvivoGen
- BioVision Inc
- Abcam
- Bristol-Myers Squibb (BMS)
- Merck
- Ono Pharmaceutical Co., Ltd
- Lilly
- Chugai Pharmaceutical Co., Ltd
- BeiGene
- Abbvie
- TG Therapeutics, Inc
- Novartis
- Arcus Biosciences
- Sino Biological Inc
- 3SBio Inc
- Monoclonal
- Polyclonal
- IHC-P
- ICC/IF
- WB
- Flow Cytometry
- ELISA
1 STUDY COVERAGE
1.1 Anti-PD-1 Antibody Product Introduction
1.2 Market Segments
1.3 Key Anti-PD-1 Antibody Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Anti-PD-1 Antibody Market Size Growth Rate by Type
1.4.2 Monoclonal
1.4.3 Polyclonal
1.5 Market by Application
1.5.1 Global Anti-PD-1 Antibody Market Size Growth Rate by Application
1.5.2 IHC-P
1.5.3 ICC/IF
1.5.4 WB
1.5.5 Flow Cytometry
1.5.6 ELISA
1.6 Coronavirus Disease 2019 (Covid-19): Anti-PD-1 Antibody Industry Impact
1.6.1 How the Covid-19 is Affecting the Anti-PD-1 Antibody Industry
1.6.1.1 Anti-PD-1 Antibody Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Anti-PD-1 Antibody Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Anti-PD-1 Antibody Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Anti-PD-1 Antibody Market Size Estimates and Forecasts
2.1.1 Global Anti-PD-1 Antibody Revenue 2015-2026
2.1.2 Global Anti-PD-1 Antibody Sales 2015-2026
2.2 Anti-PD-1 Antibody Market Size by Region: 2020 Versus 2026
2.2.1 Global Anti-PD-1 Antibody Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Anti-PD-1 Antibody Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL ANTI-PD-1 ANTIBODY COMPETITOR LANDSCAPE BY PLAYERS
3.1 Anti-PD-1 Antibody Sales by Manufacturers
3.1.1 Anti-PD-1 Antibody Sales by Manufacturers (2015-2020)
3.1.2 Anti-PD-1 Antibody Sales Market Share by Manufacturers (2015-2020)
3.2 Anti-PD-1 Antibody Revenue by Manufacturers
3.2.1 Anti-PD-1 Antibody Revenue by Manufacturers (2015-2020)
3.2.2 Anti-PD-1 Antibody Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anti-PD-1 Antibody Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Anti-PD-1 Antibody Revenue in 2019
3.2.5 Global Anti-PD-1 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Anti-PD-1 Antibody Price by Manufacturers
3.4 Anti-PD-1 Antibody Manufacturing Base Distribution, Product Types
3.4.1 Anti-PD-1 Antibody Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-PD-1 Antibody Product Type
3.4.3 Date of International Manufacturers Enter into Anti-PD-1 Antibody Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Anti-PD-1 Antibody Market Size by Type (2015-2020)
4.1.1 Global Anti-PD-1 Antibody Sales by Type (2015-2020)
4.1.2 Global Anti-PD-1 Antibody Revenue by Type (2015-2020)
4.1.3 Anti-PD-1 Antibody Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anti-PD-1 Antibody Market Size Forecast by Type (2021-2026)
4.2.1 Global Anti-PD-1 Antibody Sales Forecast by Type (2021-2026)
4.2.2 Global Anti-PD-1 Antibody Revenue Forecast by Type (2021-2026)
4.2.3 Anti-PD-1 Antibody Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anti-PD-1 Antibody Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Anti-PD-1 Antibody Market Size by Application (2015-2020)
5.1.1 Global Anti-PD-1 Antibody Sales by Application (2015-2020)
5.1.2 Global Anti-PD-1 Antibody Revenue by Application (2015-2020)
5.1.3 Anti-PD-1 Antibody Price by Application (2015-2020)
5.2 Anti-PD-1 Antibody Market Size Forecast by Application (2021-2026)
5.2.1 Global Anti-PD-1 Antibody Sales Forecast by Application (2021-2026)
5.2.2 Global Anti-PD-1 Antibody Revenue Forecast by Application (2021-2026)
5.2.3 Global Anti-PD-1 Antibody Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Anti-PD-1 Antibody by Country
6.1.1 North America Anti-PD-1 Antibody Sales by Country
6.1.2 North America Anti-PD-1 Antibody Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Anti-PD-1 Antibody Market Facts & Figures by Type
6.3 North America Anti-PD-1 Antibody Market Facts & Figures by Application
7 EUROPE
7.1 Europe Anti-PD-1 Antibody by Country
7.1.1 Europe Anti-PD-1 Antibody Sales by Country
7.1.2 Europe Anti-PD-1 Antibody Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti-PD-1 Antibody Market Facts & Figures by Type
7.3 Europe Anti-PD-1 Antibody Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Anti-PD-1 Antibody by Region
8.1.1 Asia Pacific Anti-PD-1 Antibody Sales by Region
8.1.2 Asia Pacific Anti-PD-1 Antibody Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Anti-PD-1 Antibody Market Facts & Figures by Type
8.3 Asia Pacific Anti-PD-1 Antibody Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Anti-PD-1 Antibody by Country
9.1.1 Latin America Anti-PD-1 Antibody Sales by Country
9.1.2 Latin America Anti-PD-1 Antibody Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Anti-PD-1 Antibody Market Facts & Figures by Type
9.3 Central & South America Anti-PD-1 Antibody Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Anti-PD-1 Antibody by Country
10.1.1 Middle East and Africa Anti-PD-1 Antibody Sales by Country
10.1.2 Middle East and Africa Anti-PD-1 Antibody Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Anti-PD-1 Antibody Market Facts & Figures by Type
10.3 Middle East and Africa Anti-PD-1 Antibody Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Bio X Cell
11.1.1 Bio X Cell Corporation Information
11.1.2 Bio X Cell Description, Business Overview and Total Revenue
11.1.3 Bio X Cell Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bio X Cell Anti-PD-1 Antibody Products Offered
11.1.5 Bio X Cell Recent Development
11.2 Thermo Fisher
11.2.1 Thermo Fisher Corporation Information
11.2.2 Thermo Fisher Description, Business Overview and Total Revenue
11.2.3 Thermo Fisher Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Thermo Fisher Anti-PD-1 Antibody Products Offered
11.2.5 Thermo Fisher Recent Development
11.3 InvivoGen
11.3.1 InvivoGen Corporation Information
11.3.2 InvivoGen Description, Business Overview and Total Revenue
11.3.3 InvivoGen Sales, Revenue and Gross Margin (2015-2020)
11.3.4 InvivoGen Anti-PD-1 Antibody Products Offered
11.3.5 InvivoGen Recent Development
11.4 BioVision Inc
11.4.1 BioVision Inc Corporation Information
11.4.2 BioVision Inc Description, Business Overview and Total Revenue
11.4.3 BioVision Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 BioVision Inc Anti-PD-1 Antibody Products Offered
11.4.5 BioVision Inc Recent Development
11.5 Abcam
11.5.1 Abcam Corporation Information
11.5.2 Abcam Description, Business Overview and Total Revenue
11.5.3 Abcam Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Abcam Anti-PD-1 Antibody Products Offered
11.5.5 Abcam Recent Development
11.6 Bristol-Myers Squibb (BMS)
11.6.1 Bristol-Myers Squibb (BMS) Corporation Information
11.6.2 Bristol-Myers Squibb (BMS) Description, Business Overview and Total Revenue
11.6.3 Bristol-Myers Squibb (BMS) Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Products Offered
11.6.5 Bristol-Myers Squibb (BMS) Recent Development
11.7 Merck
11.7.1 Merck Corporation Information
11.7.2 Merck Description, Business Overview and Total Revenue
11.7.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Merck Anti-PD-1 Antibody Products Offered
11.7.5 Merck Recent Development
11.8 Ono Pharmaceutical Co., Ltd
11.8.1 Ono Pharmaceutical Co., Ltd Corporation Information
11.8.2 Ono Pharmaceutical Co., Ltd Description, Business Overview and Total Revenue
11.8.3 Ono Pharmaceutical Co., Ltd Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Products Offered
11.8.5 Ono Pharmaceutical Co., Ltd Recent Development
11.9 Lilly
11.9.1 Lilly Corporation Information
11.9.2 Lilly Description, Business Overview and Total Revenue
11.9.3 Lilly Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Lilly Anti-PD-1 Antibody Products Offered
11.9.5 Lilly Recent Development
11.10 Chugai Pharmaceutical Co., Ltd
11.10.1 Chugai Pharmaceutical Co., Ltd Corporation Information
11.10.2 Chugai Pharmaceutical Co., Ltd Description, Business Overview and Total Revenue
11.10.3 Chugai Pharmaceutical Co., Ltd Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Products Offered
11.10.5 Chugai Pharmaceutical Co., Ltd Recent Development
11.1 Bio X Cell
11.1.1 Bio X Cell Corporation Information
11.1.2 Bio X Cell Description, Business Overview and Total Revenue
11.1.3 Bio X Cell Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bio X Cell Anti-PD-1 Antibody Products Offered
11.1.5 Bio X Cell Recent Development
11.12 Abbvie
11.12.1 Abbvie Corporation Information
11.12.2 Abbvie Description, Business Overview and Total Revenue
11.12.3 Abbvie Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Abbvie Products Offered
11.12.5 Abbvie Recent Development
11.13 TG Therapeutics, Inc
11.13.1 TG Therapeutics, Inc Corporation Information
11.13.2 TG Therapeutics, Inc Description, Business Overview and Total Revenue
11.13.3 TG Therapeutics, Inc Sales, Revenue and Gross Margin (2015-2020)
11.13.4 TG Therapeutics, Inc Products Offered
11.13.5 TG Therapeutics, Inc Recent Development
11.14 Novartis
11.14.1 Novartis Corporation Information
11.14.2 Novartis Description, Business Overview and Total Revenue
11.14.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Novartis Products Offered
11.14.5 Novartis Recent Development
11.15 Arcus Biosciences
11.15.1 Arcus Biosciences Corporation Information
11.15.2 Arcus Biosciences Description, Business Overview and Total Revenue
11.15.3 Arcus Biosciences Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Arcus Biosciences Products Offered
11.15.5 Arcus Biosciences Recent Development
11.16 Sino Biological Inc
11.16.1 Sino Biological Inc Corporation Information
11.16.2 Sino Biological Inc Description, Business Overview and Total Revenue
11.16.3 Sino Biological Inc Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Sino Biological Inc Products Offered
11.16.5 Sino Biological Inc Recent Development
11.17 3SBio Inc
11.17.1 3SBio Inc Corporation Information
11.17.2 3SBio Inc Description, Business Overview and Total Revenue
11.17.3 3SBio Inc Sales, Revenue and Gross Margin (2015-2020)
11.17.4 3SBio Inc Products Offered
11.17.5 3SBio Inc Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Anti-PD-1 Antibody Market Estimates and Projections by Region
12.1.1 Global Anti-PD-1 Antibody Sales Forecast by Regions 2021-2026
12.1.2 Global Anti-PD-1 Antibody Revenue Forecast by Regions 2021-2026
12.2 North America Anti-PD-1 Antibody Market Size Forecast (2021-2026)
12.2.1 North America: Anti-PD-1 Antibody Sales Forecast (2021-2026)
12.2.2 North America: Anti-PD-1 Antibody Revenue Forecast (2021-2026)
12.2.3 North America: Anti-PD-1 Antibody Market Size Forecast by Country (2021-2026)
12.3 Europe Anti-PD-1 Antibody Market Size Forecast (2021-2026)
12.3.1 Europe: Anti-PD-1 Antibody Sales Forecast (2021-2026)
12.3.2 Europe: Anti-PD-1 Antibody Revenue Forecast (2021-2026)
12.3.3 Europe: Anti-PD-1 Antibody Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Anti-PD-1 Antibody Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Anti-PD-1 Antibody Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Anti-PD-1 Antibody Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Anti-PD-1 Antibody Market Size Forecast by Region (2021-2026)
12.5 Latin America Anti-PD-1 Antibody Market Size Forecast (2021-2026)
12.5.1 Latin America: Anti-PD-1 Antibody Sales Forecast (2021-2026)
12.5.2 Latin America: Anti-PD-1 Antibody Revenue Forecast (2021-2026)
12.5.3 Latin America: Anti-PD-1 Antibody Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Anti-PD-1 Antibody Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Anti-PD-1 Antibody Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Anti-PD-1 Antibody Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Anti-PD-1 Antibody Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Anti-PD-1 Antibody Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Anti-PD-1 Antibody Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Anti-PD-1 Antibody Product Introduction
1.2 Market Segments
1.3 Key Anti-PD-1 Antibody Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Anti-PD-1 Antibody Market Size Growth Rate by Type
1.4.2 Monoclonal
1.4.3 Polyclonal
1.5 Market by Application
1.5.1 Global Anti-PD-1 Antibody Market Size Growth Rate by Application
1.5.2 IHC-P
1.5.3 ICC/IF
1.5.4 WB
1.5.5 Flow Cytometry
1.5.6 ELISA
1.6 Coronavirus Disease 2019 (Covid-19): Anti-PD-1 Antibody Industry Impact
1.6.1 How the Covid-19 is Affecting the Anti-PD-1 Antibody Industry
1.6.1.1 Anti-PD-1 Antibody Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Anti-PD-1 Antibody Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Anti-PD-1 Antibody Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Anti-PD-1 Antibody Market Size Estimates and Forecasts
2.1.1 Global Anti-PD-1 Antibody Revenue 2015-2026
2.1.2 Global Anti-PD-1 Antibody Sales 2015-2026
2.2 Anti-PD-1 Antibody Market Size by Region: 2020 Versus 2026
2.2.1 Global Anti-PD-1 Antibody Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Anti-PD-1 Antibody Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL ANTI-PD-1 ANTIBODY COMPETITOR LANDSCAPE BY PLAYERS
3.1 Anti-PD-1 Antibody Sales by Manufacturers
3.1.1 Anti-PD-1 Antibody Sales by Manufacturers (2015-2020)
3.1.2 Anti-PD-1 Antibody Sales Market Share by Manufacturers (2015-2020)
3.2 Anti-PD-1 Antibody Revenue by Manufacturers
3.2.1 Anti-PD-1 Antibody Revenue by Manufacturers (2015-2020)
3.2.2 Anti-PD-1 Antibody Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anti-PD-1 Antibody Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Anti-PD-1 Antibody Revenue in 2019
3.2.5 Global Anti-PD-1 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Anti-PD-1 Antibody Price by Manufacturers
3.4 Anti-PD-1 Antibody Manufacturing Base Distribution, Product Types
3.4.1 Anti-PD-1 Antibody Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-PD-1 Antibody Product Type
3.4.3 Date of International Manufacturers Enter into Anti-PD-1 Antibody Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Anti-PD-1 Antibody Market Size by Type (2015-2020)
4.1.1 Global Anti-PD-1 Antibody Sales by Type (2015-2020)
4.1.2 Global Anti-PD-1 Antibody Revenue by Type (2015-2020)
4.1.3 Anti-PD-1 Antibody Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anti-PD-1 Antibody Market Size Forecast by Type (2021-2026)
4.2.1 Global Anti-PD-1 Antibody Sales Forecast by Type (2021-2026)
4.2.2 Global Anti-PD-1 Antibody Revenue Forecast by Type (2021-2026)
4.2.3 Anti-PD-1 Antibody Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anti-PD-1 Antibody Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Anti-PD-1 Antibody Market Size by Application (2015-2020)
5.1.1 Global Anti-PD-1 Antibody Sales by Application (2015-2020)
5.1.2 Global Anti-PD-1 Antibody Revenue by Application (2015-2020)
5.1.3 Anti-PD-1 Antibody Price by Application (2015-2020)
5.2 Anti-PD-1 Antibody Market Size Forecast by Application (2021-2026)
5.2.1 Global Anti-PD-1 Antibody Sales Forecast by Application (2021-2026)
5.2.2 Global Anti-PD-1 Antibody Revenue Forecast by Application (2021-2026)
5.2.3 Global Anti-PD-1 Antibody Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Anti-PD-1 Antibody by Country
6.1.1 North America Anti-PD-1 Antibody Sales by Country
6.1.2 North America Anti-PD-1 Antibody Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Anti-PD-1 Antibody Market Facts & Figures by Type
6.3 North America Anti-PD-1 Antibody Market Facts & Figures by Application
7 EUROPE
7.1 Europe Anti-PD-1 Antibody by Country
7.1.1 Europe Anti-PD-1 Antibody Sales by Country
7.1.2 Europe Anti-PD-1 Antibody Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti-PD-1 Antibody Market Facts & Figures by Type
7.3 Europe Anti-PD-1 Antibody Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Anti-PD-1 Antibody by Region
8.1.1 Asia Pacific Anti-PD-1 Antibody Sales by Region
8.1.2 Asia Pacific Anti-PD-1 Antibody Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Anti-PD-1 Antibody Market Facts & Figures by Type
8.3 Asia Pacific Anti-PD-1 Antibody Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Anti-PD-1 Antibody by Country
9.1.1 Latin America Anti-PD-1 Antibody Sales by Country
9.1.2 Latin America Anti-PD-1 Antibody Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Anti-PD-1 Antibody Market Facts & Figures by Type
9.3 Central & South America Anti-PD-1 Antibody Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Anti-PD-1 Antibody by Country
10.1.1 Middle East and Africa Anti-PD-1 Antibody Sales by Country
10.1.2 Middle East and Africa Anti-PD-1 Antibody Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Anti-PD-1 Antibody Market Facts & Figures by Type
10.3 Middle East and Africa Anti-PD-1 Antibody Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Bio X Cell
11.1.1 Bio X Cell Corporation Information
11.1.2 Bio X Cell Description, Business Overview and Total Revenue
11.1.3 Bio X Cell Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bio X Cell Anti-PD-1 Antibody Products Offered
11.1.5 Bio X Cell Recent Development
11.2 Thermo Fisher
11.2.1 Thermo Fisher Corporation Information
11.2.2 Thermo Fisher Description, Business Overview and Total Revenue
11.2.3 Thermo Fisher Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Thermo Fisher Anti-PD-1 Antibody Products Offered
11.2.5 Thermo Fisher Recent Development
11.3 InvivoGen
11.3.1 InvivoGen Corporation Information
11.3.2 InvivoGen Description, Business Overview and Total Revenue
11.3.3 InvivoGen Sales, Revenue and Gross Margin (2015-2020)
11.3.4 InvivoGen Anti-PD-1 Antibody Products Offered
11.3.5 InvivoGen Recent Development
11.4 BioVision Inc
11.4.1 BioVision Inc Corporation Information
11.4.2 BioVision Inc Description, Business Overview and Total Revenue
11.4.3 BioVision Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 BioVision Inc Anti-PD-1 Antibody Products Offered
11.4.5 BioVision Inc Recent Development
11.5 Abcam
11.5.1 Abcam Corporation Information
11.5.2 Abcam Description, Business Overview and Total Revenue
11.5.3 Abcam Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Abcam Anti-PD-1 Antibody Products Offered
11.5.5 Abcam Recent Development
11.6 Bristol-Myers Squibb (BMS)
11.6.1 Bristol-Myers Squibb (BMS) Corporation Information
11.6.2 Bristol-Myers Squibb (BMS) Description, Business Overview and Total Revenue
11.6.3 Bristol-Myers Squibb (BMS) Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Products Offered
11.6.5 Bristol-Myers Squibb (BMS) Recent Development
11.7 Merck
11.7.1 Merck Corporation Information
11.7.2 Merck Description, Business Overview and Total Revenue
11.7.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Merck Anti-PD-1 Antibody Products Offered
11.7.5 Merck Recent Development
11.8 Ono Pharmaceutical Co., Ltd
11.8.1 Ono Pharmaceutical Co., Ltd Corporation Information
11.8.2 Ono Pharmaceutical Co., Ltd Description, Business Overview and Total Revenue
11.8.3 Ono Pharmaceutical Co., Ltd Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Products Offered
11.8.5 Ono Pharmaceutical Co., Ltd Recent Development
11.9 Lilly
11.9.1 Lilly Corporation Information
11.9.2 Lilly Description, Business Overview and Total Revenue
11.9.3 Lilly Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Lilly Anti-PD-1 Antibody Products Offered
11.9.5 Lilly Recent Development
11.10 Chugai Pharmaceutical Co., Ltd
11.10.1 Chugai Pharmaceutical Co., Ltd Corporation Information
11.10.2 Chugai Pharmaceutical Co., Ltd Description, Business Overview and Total Revenue
11.10.3 Chugai Pharmaceutical Co., Ltd Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Products Offered
11.10.5 Chugai Pharmaceutical Co., Ltd Recent Development
11.1 Bio X Cell
11.1.1 Bio X Cell Corporation Information
11.1.2 Bio X Cell Description, Business Overview and Total Revenue
11.1.3 Bio X Cell Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bio X Cell Anti-PD-1 Antibody Products Offered
11.1.5 Bio X Cell Recent Development
11.12 Abbvie
11.12.1 Abbvie Corporation Information
11.12.2 Abbvie Description, Business Overview and Total Revenue
11.12.3 Abbvie Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Abbvie Products Offered
11.12.5 Abbvie Recent Development
11.13 TG Therapeutics, Inc
11.13.1 TG Therapeutics, Inc Corporation Information
11.13.2 TG Therapeutics, Inc Description, Business Overview and Total Revenue
11.13.3 TG Therapeutics, Inc Sales, Revenue and Gross Margin (2015-2020)
11.13.4 TG Therapeutics, Inc Products Offered
11.13.5 TG Therapeutics, Inc Recent Development
11.14 Novartis
11.14.1 Novartis Corporation Information
11.14.2 Novartis Description, Business Overview and Total Revenue
11.14.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Novartis Products Offered
11.14.5 Novartis Recent Development
11.15 Arcus Biosciences
11.15.1 Arcus Biosciences Corporation Information
11.15.2 Arcus Biosciences Description, Business Overview and Total Revenue
11.15.3 Arcus Biosciences Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Arcus Biosciences Products Offered
11.15.5 Arcus Biosciences Recent Development
11.16 Sino Biological Inc
11.16.1 Sino Biological Inc Corporation Information
11.16.2 Sino Biological Inc Description, Business Overview and Total Revenue
11.16.3 Sino Biological Inc Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Sino Biological Inc Products Offered
11.16.5 Sino Biological Inc Recent Development
11.17 3SBio Inc
11.17.1 3SBio Inc Corporation Information
11.17.2 3SBio Inc Description, Business Overview and Total Revenue
11.17.3 3SBio Inc Sales, Revenue and Gross Margin (2015-2020)
11.17.4 3SBio Inc Products Offered
11.17.5 3SBio Inc Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Anti-PD-1 Antibody Market Estimates and Projections by Region
12.1.1 Global Anti-PD-1 Antibody Sales Forecast by Regions 2021-2026
12.1.2 Global Anti-PD-1 Antibody Revenue Forecast by Regions 2021-2026
12.2 North America Anti-PD-1 Antibody Market Size Forecast (2021-2026)
12.2.1 North America: Anti-PD-1 Antibody Sales Forecast (2021-2026)
12.2.2 North America: Anti-PD-1 Antibody Revenue Forecast (2021-2026)
12.2.3 North America: Anti-PD-1 Antibody Market Size Forecast by Country (2021-2026)
12.3 Europe Anti-PD-1 Antibody Market Size Forecast (2021-2026)
12.3.1 Europe: Anti-PD-1 Antibody Sales Forecast (2021-2026)
12.3.2 Europe: Anti-PD-1 Antibody Revenue Forecast (2021-2026)
12.3.3 Europe: Anti-PD-1 Antibody Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Anti-PD-1 Antibody Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Anti-PD-1 Antibody Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Anti-PD-1 Antibody Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Anti-PD-1 Antibody Market Size Forecast by Region (2021-2026)
12.5 Latin America Anti-PD-1 Antibody Market Size Forecast (2021-2026)
12.5.1 Latin America: Anti-PD-1 Antibody Sales Forecast (2021-2026)
12.5.2 Latin America: Anti-PD-1 Antibody Revenue Forecast (2021-2026)
12.5.3 Latin America: Anti-PD-1 Antibody Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Anti-PD-1 Antibody Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Anti-PD-1 Antibody Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Anti-PD-1 Antibody Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Anti-PD-1 Antibody Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Anti-PD-1 Antibody Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Anti-PD-1 Antibody Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Anti-PD-1 Antibody Market Segments
Table 2. Ranking of Global Top Anti-PD-1 Antibody Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anti-PD-1 Antibody Market Size Growth Rate by Type 2020-2026 (Kg) & (US$ Million)
Table 4. Major Manufacturers of Monoclonal
Table 5. Major Manufacturers of Polyclonal
Table 6. COVID-19 Impact Global Market: (Four Anti-PD-1 Antibody Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Anti-PD-1 Antibody Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Anti-PD-1 Antibody Players to Combat Covid-19 Impact
Table 11. Global Anti-PD-1 Antibody Market Size Growth Rate by Application 2020-2026 (Kg)
Table 12. Global Anti-PD-1 Antibody Market Size by Region (Kg) & (US$ Million): 2020 VS 2026
Table 13. Global Anti-PD-1 Antibody Sales by Regions 2015-2020 (Kg)
Table 14. Global Anti-PD-1 Antibody Sales Market Share by Regions (2015-2020)
Table 15. Global Anti-PD-1 Antibody Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Anti-PD-1 Antibody Sales by Manufacturers (2015-2020) (Kg)
Table 17. Global Anti-PD-1 Antibody Sales Share by Manufacturers (2015-2020)
Table 18. Global Anti-PD-1 Antibody Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Anti-PD-1 Antibody by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-PD-1 Antibody as of 2019)
Table 20. Anti-PD-1 Antibody Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Anti-PD-1 Antibody Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Anti-PD-1 Antibody Price (2015-2020) (USD/g)
Table 23. Anti-PD-1 Antibody Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Anti-PD-1 Antibody Product Type
Table 25. Date of International Manufacturers Enter into Anti-PD-1 Antibody Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Anti-PD-1 Antibody Sales by Type (2015-2020) (Kg)
Table 28. Global Anti-PD-1 Antibody Sales Share by Type (2015-2020)
Table 29. Global Anti-PD-1 Antibody Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Anti-PD-1 Antibody Revenue Share by Type (2015-2020)
Table 31. Anti-PD-1 Antibody Average Selling Price (ASP) by Type 2015-2020 (USD/g)
Table 32. Global Anti-PD-1 Antibody Sales by Application (2015-2020) (Kg)
Table 33. Global Anti-PD-1 Antibody Sales Share by Application (2015-2020)
Table 34. North America Anti-PD-1 Antibody Sales by Country (2015-2020) (Kg)
Table 35. North America Anti-PD-1 Antibody Sales Market Share by Country (2015-2020)
Table 36. North America Anti-PD-1 Antibody Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Anti-PD-1 Antibody Revenue Market Share by Country (2015-2020)
Table 38. North America Anti-PD-1 Antibody Sales by Type (2015-2020) (Kg)
Table 39. North America Anti-PD-1 Antibody Sales Market Share by Type (2015-2020)
Table 40. North America Anti-PD-1 Antibody Sales by Application (2015-2020) (Kg)
Table 41. North America Anti-PD-1 Antibody Sales Market Share by Application (2015-2020)
Table 42. Europe Anti-PD-1 Antibody Sales by Country (2015-2020) (Kg)
Table 43. Europe Anti-PD-1 Antibody Sales Market Share by Country (2015-2020)
Table 44. Europe Anti-PD-1 Antibody Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Anti-PD-1 Antibody Revenue Market Share by Country (2015-2020)
Table 46. Europe Anti-PD-1 Antibody Sales by Type (2015-2020) (Kg)
Table 47. Europe Anti-PD-1 Antibody Sales Market Share by Type (2015-2020)
Table 48. Europe Anti-PD-1 Antibody Sales by Application (2015-2020) (Kg)
Table 49. Europe Anti-PD-1 Antibody Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Anti-PD-1 Antibody Sales by Region (2015-2020) (Kg)
Table 51. Asia Pacific Anti-PD-1 Antibody Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Anti-PD-1 Antibody Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Anti-PD-1 Antibody Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Anti-PD-1 Antibody Sales by Type (2015-2020) (Kg)
Table 55. Asia Pacific Anti-PD-1 Antibody Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Anti-PD-1 Antibody Sales by Application (2015-2020) (Kg)
Table 57. Asia Pacific Anti-PD-1 Antibody Sales Market Share by Application (2015-2020)
Table 58. Latin America Anti-PD-1 Antibody Sales by Country (2015-2020) (Kg)
Table 59. Latin America Anti-PD-1 Antibody Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Anti-PD-1 Antibody Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Anti-PD-1 Antibody Revenue Market Share by Country (2015-2020)
Table 62. Latin America Anti-PD-1 Antibody Sales by Type (2015-2020) (Kg)
Table 63. Latin America Anti-PD-1 Antibody Sales Market Share by Type (2015-2020)
Table 64. Latin America Anti-PD-1 Antibody Sales by Application (2015-2020) (Kg)
Table 65. Latin America Anti-PD-1 Antibody Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Anti-PD-1 Antibody Sales by Country (2015-2020) (Kg)
Table 67. Middle East and Africa Anti-PD-1 Antibody Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Anti-PD-1 Antibody Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Anti-PD-1 Antibody Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Anti-PD-1 Antibody Sales by Type (2015-2020) (Kg)
Table 71. Middle East and Africa Anti-PD-1 Antibody Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Anti-PD-1 Antibody Sales by Application (2015-2020) (Kg)
Table 73. Middle East and Africa Anti-PD-1 Antibody Sales Market Share by Application (2015-2020)
Table 74. Bio X Cell Corporation Information
Table 75. Bio X Cell Description and Major Businesses
Table 76. Bio X Cell Anti-PD-1 Antibody Production (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 77. Bio X Cell Product
Table 78. Bio X Cell Recent Development
Table 79. Thermo Fisher Corporation Information
Table 80. Thermo Fisher Description and Major Businesses
Table 81. Thermo Fisher Anti-PD-1 Antibody Production (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 82. Thermo Fisher Product
Table 83. Thermo Fisher Recent Development
Table 84. InvivoGen Corporation Information
Table 85. InvivoGen Description and Major Businesses
Table 86. InvivoGen Anti-PD-1 Antibody Production (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 87. InvivoGen Product
Table 88. InvivoGen Recent Development
Table 89. BioVision Inc Corporation Information
Table 90. BioVision Inc Description and Major Businesses
Table 91. BioVision Inc Anti-PD-1 Antibody Production (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 92. BioVision Inc Product
Table 93. BioVision Inc Recent Development
Table 94. Abcam Corporation Information
Table 95. Abcam Description and Major Businesses
Table 96. Abcam Anti-PD-1 Antibody Production (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 97. Abcam Product
Table 98. Abcam Recent Development
Table 99. Bristol-Myers Squibb (BMS) Corporation Information
Table 100. Bristol-Myers Squibb (BMS) Description and Major Businesses
Table 101. Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Production (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 102. Bristol-Myers Squibb (BMS) Product
Table 103. Bristol-Myers Squibb (BMS) Recent Development
Table 104. Merck Corporation Information
Table 105. Merck Description and Major Businesses
Table 106. Merck Anti-PD-1 Antibody Production (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 107. Merck Product
Table 108. Merck Recent Development
Table 109. Ono Pharmaceutical Co., Ltd Corporation Information
Table 110. Ono Pharmaceutical Co., Ltd Description and Major Businesses
Table 111. Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Production (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 112. Ono Pharmaceutical Co., Ltd Product
Table 113. Ono Pharmaceutical Co., Ltd Recent Development
Table 114. Lilly Corporation Information
Table 115. Lilly Description and Major Businesses
Table 116. Lilly Anti-PD-1 Antibody Production (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 117. Lilly Product
Table 118. Lilly Recent Development
Table 119. Chugai Pharmaceutical Co., Ltd Corporation Information
Table 120. Chugai Pharmaceutical Co., Ltd Description and Major Businesses
Table 121. Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Production (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 122. Chugai Pharmaceutical Co., Ltd Product
Table 123. Chugai Pharmaceutical Co., Ltd Recent Development
Table 124. BeiGene Corporation Information
Table 125. BeiGene Description and Major Businesses
Table 126. BeiGene Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 127. BeiGene Product
Table 128. BeiGene Recent Development
Table 129. Abbvie Corporation Information
Table 130. Abbvie Description and Major Businesses
Table 131. Abbvie Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 132. Abbvie Product
Table 133. Abbvie Recent Development
Table 134. TG Therapeutics, Inc Corporation Information
Table 135. TG Therapeutics, Inc Description and Major Businesses
Table 136. TG Therapeutics, Inc Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 137. TG Therapeutics, Inc Product
Table 138. TG Therapeutics, Inc Recent Development
Table 139. Novartis Corporation Information
Table 140. Novartis Description and Major Businesses
Table 141. Novartis Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 142. Novartis Product
Table 143. Novartis Recent Development
Table 144. Arcus Biosciences Corporation Information
Table 145. Arcus Biosciences Description and Major Businesses
Table 146. Arcus Biosciences Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 147. Arcus Biosciences Product
Table 148. Arcus Biosciences Recent Development
Table 149. Sino Biological Inc Corporation Information
Table 150. Sino Biological Inc Description and Major Businesses
Table 151. Sino Biological Inc Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 152. Sino Biological Inc Product
Table 153. Sino Biological Inc Recent Development
Table 154. 3SBio Inc Corporation Information
Table 155. 3SBio Inc Description and Major Businesses
Table 156. 3SBio Inc Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 157. 3SBio Inc Product
Table 158. 3SBio Inc Recent Development
Table 159. Global Anti-PD-1 Antibody Sales Forecast by Regions (2021-2026) (Kg)
Table 160. Global Anti-PD-1 Antibody Sales Market Share Forecast by Regions (2021-2026)
Table 161. Global Anti-PD-1 Antibody Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 162. Global Anti-PD-1 Antibody Revenue Market Share Forecast by Regions (2021-2026)
Table 163. North America: Anti-PD-1 Antibody Sales Forecast by Country (2021-2026) (Kg)
Table 164. North America: Anti-PD-1 Antibody Revenue Forecast by Country (2021-2026) (US$ Million)
Table 165. Europe: Anti-PD-1 Antibody Sales Forecast by Country (2021-2026) (Kg)
Table 166. Europe: Anti-PD-1 Antibody Revenue Forecast by Country (2021-2026) (US$ Million)
Table 167. Asia Pacific: Anti-PD-1 Antibody Sales Forecast by Region (2021-2026) (Kg)
Table 168. Asia Pacific: Anti-PD-1 Antibody Revenue Forecast by Region (2021-2026) (US$ Million)
Table 169. Latin America: Anti-PD-1 Antibody Sales Forecast by Country (2021-2026) (Kg)
Table 170. Latin America: Anti-PD-1 Antibody Revenue Forecast by Country (2021-2026) (US$ Million)
Table 171. Middle East and Africa: Anti-PD-1 Antibody Sales Forecast by Country (2021-2026) (Kg)
Table 172. Middle East and Africa: Anti-PD-1 Antibody Revenue Forecast by Country (2021-2026) (US$ Million)
Table 173. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 174. Key Challenges
Table 175. Market Risks
Table 176. Main Points Interviewed from Key Anti-PD-1 Antibody Players
Table 177. Anti-PD-1 Antibody Customers List
Table 178. Anti-PD-1 Antibody Distributors List
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
Table 1. Anti-PD-1 Antibody Market Segments
Table 2. Ranking of Global Top Anti-PD-1 Antibody Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anti-PD-1 Antibody Market Size Growth Rate by Type 2020-2026 (Kg) & (US$ Million)
Table 4. Major Manufacturers of Monoclonal
Table 5. Major Manufacturers of Polyclonal
Table 6. COVID-19 Impact Global Market: (Four Anti-PD-1 Antibody Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Anti-PD-1 Antibody Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Anti-PD-1 Antibody Players to Combat Covid-19 Impact
Table 11. Global Anti-PD-1 Antibody Market Size Growth Rate by Application 2020-2026 (Kg)
Table 12. Global Anti-PD-1 Antibody Market Size by Region (Kg) & (US$ Million): 2020 VS 2026
Table 13. Global Anti-PD-1 Antibody Sales by Regions 2015-2020 (Kg)
Table 14. Global Anti-PD-1 Antibody Sales Market Share by Regions (2015-2020)
Table 15. Global Anti-PD-1 Antibody Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Anti-PD-1 Antibody Sales by Manufacturers (2015-2020) (Kg)
Table 17. Global Anti-PD-1 Antibody Sales Share by Manufacturers (2015-2020)
Table 18. Global Anti-PD-1 Antibody Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Anti-PD-1 Antibody by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-PD-1 Antibody as of 2019)
Table 20. Anti-PD-1 Antibody Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Anti-PD-1 Antibody Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Anti-PD-1 Antibody Price (2015-2020) (USD/g)
Table 23. Anti-PD-1 Antibody Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Anti-PD-1 Antibody Product Type
Table 25. Date of International Manufacturers Enter into Anti-PD-1 Antibody Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Anti-PD-1 Antibody Sales by Type (2015-2020) (Kg)
Table 28. Global Anti-PD-1 Antibody Sales Share by Type (2015-2020)
Table 29. Global Anti-PD-1 Antibody Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Anti-PD-1 Antibody Revenue Share by Type (2015-2020)
Table 31. Anti-PD-1 Antibody Average Selling Price (ASP) by Type 2015-2020 (USD/g)
Table 32. Global Anti-PD-1 Antibody Sales by Application (2015-2020) (Kg)
Table 33. Global Anti-PD-1 Antibody Sales Share by Application (2015-2020)
Table 34. North America Anti-PD-1 Antibody Sales by Country (2015-2020) (Kg)
Table 35. North America Anti-PD-1 Antibody Sales Market Share by Country (2015-2020)
Table 36. North America Anti-PD-1 Antibody Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Anti-PD-1 Antibody Revenue Market Share by Country (2015-2020)
Table 38. North America Anti-PD-1 Antibody Sales by Type (2015-2020) (Kg)
Table 39. North America Anti-PD-1 Antibody Sales Market Share by Type (2015-2020)
Table 40. North America Anti-PD-1 Antibody Sales by Application (2015-2020) (Kg)
Table 41. North America Anti-PD-1 Antibody Sales Market Share by Application (2015-2020)
Table 42. Europe Anti-PD-1 Antibody Sales by Country (2015-2020) (Kg)
Table 43. Europe Anti-PD-1 Antibody Sales Market Share by Country (2015-2020)
Table 44. Europe Anti-PD-1 Antibody Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Anti-PD-1 Antibody Revenue Market Share by Country (2015-2020)
Table 46. Europe Anti-PD-1 Antibody Sales by Type (2015-2020) (Kg)
Table 47. Europe Anti-PD-1 Antibody Sales Market Share by Type (2015-2020)
Table 48. Europe Anti-PD-1 Antibody Sales by Application (2015-2020) (Kg)
Table 49. Europe Anti-PD-1 Antibody Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Anti-PD-1 Antibody Sales by Region (2015-2020) (Kg)
Table 51. Asia Pacific Anti-PD-1 Antibody Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Anti-PD-1 Antibody Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Anti-PD-1 Antibody Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Anti-PD-1 Antibody Sales by Type (2015-2020) (Kg)
Table 55. Asia Pacific Anti-PD-1 Antibody Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Anti-PD-1 Antibody Sales by Application (2015-2020) (Kg)
Table 57. Asia Pacific Anti-PD-1 Antibody Sales Market Share by Application (2015-2020)
Table 58. Latin America Anti-PD-1 Antibody Sales by Country (2015-2020) (Kg)
Table 59. Latin America Anti-PD-1 Antibody Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Anti-PD-1 Antibody Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Anti-PD-1 Antibody Revenue Market Share by Country (2015-2020)
Table 62. Latin America Anti-PD-1 Antibody Sales by Type (2015-2020) (Kg)
Table 63. Latin America Anti-PD-1 Antibody Sales Market Share by Type (2015-2020)
Table 64. Latin America Anti-PD-1 Antibody Sales by Application (2015-2020) (Kg)
Table 65. Latin America Anti-PD-1 Antibody Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Anti-PD-1 Antibody Sales by Country (2015-2020) (Kg)
Table 67. Middle East and Africa Anti-PD-1 Antibody Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Anti-PD-1 Antibody Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Anti-PD-1 Antibody Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Anti-PD-1 Antibody Sales by Type (2015-2020) (Kg)
Table 71. Middle East and Africa Anti-PD-1 Antibody Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Anti-PD-1 Antibody Sales by Application (2015-2020) (Kg)
Table 73. Middle East and Africa Anti-PD-1 Antibody Sales Market Share by Application (2015-2020)
Table 74. Bio X Cell Corporation Information
Table 75. Bio X Cell Description and Major Businesses
Table 76. Bio X Cell Anti-PD-1 Antibody Production (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 77. Bio X Cell Product
Table 78. Bio X Cell Recent Development
Table 79. Thermo Fisher Corporation Information
Table 80. Thermo Fisher Description and Major Businesses
Table 81. Thermo Fisher Anti-PD-1 Antibody Production (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 82. Thermo Fisher Product
Table 83. Thermo Fisher Recent Development
Table 84. InvivoGen Corporation Information
Table 85. InvivoGen Description and Major Businesses
Table 86. InvivoGen Anti-PD-1 Antibody Production (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 87. InvivoGen Product
Table 88. InvivoGen Recent Development
Table 89. BioVision Inc Corporation Information
Table 90. BioVision Inc Description and Major Businesses
Table 91. BioVision Inc Anti-PD-1 Antibody Production (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 92. BioVision Inc Product
Table 93. BioVision Inc Recent Development
Table 94. Abcam Corporation Information
Table 95. Abcam Description and Major Businesses
Table 96. Abcam Anti-PD-1 Antibody Production (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 97. Abcam Product
Table 98. Abcam Recent Development
Table 99. Bristol-Myers Squibb (BMS) Corporation Information
Table 100. Bristol-Myers Squibb (BMS) Description and Major Businesses
Table 101. Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Production (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 102. Bristol-Myers Squibb (BMS) Product
Table 103. Bristol-Myers Squibb (BMS) Recent Development
Table 104. Merck Corporation Information
Table 105. Merck Description and Major Businesses
Table 106. Merck Anti-PD-1 Antibody Production (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 107. Merck Product
Table 108. Merck Recent Development
Table 109. Ono Pharmaceutical Co., Ltd Corporation Information
Table 110. Ono Pharmaceutical Co., Ltd Description and Major Businesses
Table 111. Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Production (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 112. Ono Pharmaceutical Co., Ltd Product
Table 113. Ono Pharmaceutical Co., Ltd Recent Development
Table 114. Lilly Corporation Information
Table 115. Lilly Description and Major Businesses
Table 116. Lilly Anti-PD-1 Antibody Production (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 117. Lilly Product
Table 118. Lilly Recent Development
Table 119. Chugai Pharmaceutical Co., Ltd Corporation Information
Table 120. Chugai Pharmaceutical Co., Ltd Description and Major Businesses
Table 121. Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Production (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 122. Chugai Pharmaceutical Co., Ltd Product
Table 123. Chugai Pharmaceutical Co., Ltd Recent Development
Table 124. BeiGene Corporation Information
Table 125. BeiGene Description and Major Businesses
Table 126. BeiGene Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 127. BeiGene Product
Table 128. BeiGene Recent Development
Table 129. Abbvie Corporation Information
Table 130. Abbvie Description and Major Businesses
Table 131. Abbvie Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 132. Abbvie Product
Table 133. Abbvie Recent Development
Table 134. TG Therapeutics, Inc Corporation Information
Table 135. TG Therapeutics, Inc Description and Major Businesses
Table 136. TG Therapeutics, Inc Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 137. TG Therapeutics, Inc Product
Table 138. TG Therapeutics, Inc Recent Development
Table 139. Novartis Corporation Information
Table 140. Novartis Description and Major Businesses
Table 141. Novartis Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 142. Novartis Product
Table 143. Novartis Recent Development
Table 144. Arcus Biosciences Corporation Information
Table 145. Arcus Biosciences Description and Major Businesses
Table 146. Arcus Biosciences Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 147. Arcus Biosciences Product
Table 148. Arcus Biosciences Recent Development
Table 149. Sino Biological Inc Corporation Information
Table 150. Sino Biological Inc Description and Major Businesses
Table 151. Sino Biological Inc Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 152. Sino Biological Inc Product
Table 153. Sino Biological Inc Recent Development
Table 154. 3SBio Inc Corporation Information
Table 155. 3SBio Inc Description and Major Businesses
Table 156. 3SBio Inc Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 157. 3SBio Inc Product
Table 158. 3SBio Inc Recent Development
Table 159. Global Anti-PD-1 Antibody Sales Forecast by Regions (2021-2026) (Kg)
Table 160. Global Anti-PD-1 Antibody Sales Market Share Forecast by Regions (2021-2026)
Table 161. Global Anti-PD-1 Antibody Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 162. Global Anti-PD-1 Antibody Revenue Market Share Forecast by Regions (2021-2026)
Table 163. North America: Anti-PD-1 Antibody Sales Forecast by Country (2021-2026) (Kg)
Table 164. North America: Anti-PD-1 Antibody Revenue Forecast by Country (2021-2026) (US$ Million)
Table 165. Europe: Anti-PD-1 Antibody Sales Forecast by Country (2021-2026) (Kg)
Table 166. Europe: Anti-PD-1 Antibody Revenue Forecast by Country (2021-2026) (US$ Million)
Table 167. Asia Pacific: Anti-PD-1 Antibody Sales Forecast by Region (2021-2026) (Kg)
Table 168. Asia Pacific: Anti-PD-1 Antibody Revenue Forecast by Region (2021-2026) (US$ Million)
Table 169. Latin America: Anti-PD-1 Antibody Sales Forecast by Country (2021-2026) (Kg)
Table 170. Latin America: Anti-PD-1 Antibody Revenue Forecast by Country (2021-2026) (US$ Million)
Table 171. Middle East and Africa: Anti-PD-1 Antibody Sales Forecast by Country (2021-2026) (Kg)
Table 172. Middle East and Africa: Anti-PD-1 Antibody Revenue Forecast by Country (2021-2026) (US$ Million)
Table 173. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 174. Key Challenges
Table 175. Market Risks
Table 176. Main Points Interviewed from Key Anti-PD-1 Antibody Players
Table 177. Anti-PD-1 Antibody Customers List
Table 178. Anti-PD-1 Antibody Distributors List
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Anti-PD-1 Antibody Product Picture
Figure 2. Global Anti-PD-1 Antibody Sales Market Share by Type in 2020 & 2026
Figure 3. Monoclonal Product Picture
Figure 4. Polyclonal Product Picture
Figure 5. Global Anti-PD-1 Antibody Sales Market Share by Application in 2020 & 2026
Figure 6. IHC-P
Figure 7. ICC/IF
Figure 8. WB
Figure 9. Flow Cytometry
Figure 10. ELISA
Figure 11. Anti-PD-1 Antibody Report Years Considered
Figure 12. Global Anti-PD-1 Antibody Market Size 2015-2026 (US$ Million)
Figure 13. Global Anti-PD-1 Antibody Sales 2015-2026 (Kg)
Figure 14. Global Anti-PD-1 Antibody Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Anti-PD-1 Antibody Sales Market Share by Region (2015-2020)
Figure 16. Global Anti-PD-1 Antibody Sales Market Share by Region in 2019
Figure 17. Global Anti-PD-1 Antibody Revenue Market Share by Region (2015-2020)
Figure 18. Global Anti-PD-1 Antibody Revenue Market Share by Region in 2019
Figure 19. Global Anti-PD-1 Antibody Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Anti-PD-1 Antibody Revenue in 2019
Figure 21. Anti-PD-1 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Anti-PD-1 Antibody Sales Market Share by Type (2015-2020)
Figure 23. Global Anti-PD-1 Antibody Sales Market Share by Type in 2019
Figure 24. Global Anti-PD-1 Antibody Revenue Market Share by Type (2015-2020)
Figure 25. Global Anti-PD-1 Antibody Revenue Market Share by Type in 2019
Figure 26. Global Anti-PD-1 Antibody Market Share by Price Range (2015-2020)
Figure 27. Global Anti-PD-1 Antibody Sales Market Share by Application (2015-2020)
Figure 28. Global Anti-PD-1 Antibody Sales Market Share by Application in 2019
Figure 29. Global Anti-PD-1 Antibody Revenue Market Share by Application (2015-2020)
Figure 30. Global Anti-PD-1 Antibody Revenue Market Share by Application in 2019
Figure 31. North America Anti-PD-1 Antibody Sales Growth Rate 2015-2020 (Kg)
Figure 32. North America Anti-PD-1 Antibody Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Anti-PD-1 Antibody Sales Market Share by Country in 2019
Figure 34. North America Anti-PD-1 Antibody Revenue Market Share by Country in 2019
Figure 35. U.S. Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 36. U.S. Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 38. Canada Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Anti-PD-1 Antibody Market Share by Type in 2019
Figure 40. North America Anti-PD-1 Antibody Market Share by Application in 2019
Figure 41. Europe Anti-PD-1 Antibody Sales Growth Rate 2015-2020 (Kg)
Figure 42. Europe Anti-PD-1 Antibody Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Anti-PD-1 Antibody Sales Market Share by Country in 2019
Figure 44. Europe Anti-PD-1 Antibody Revenue Market Share by Country in 2019
Figure 45. Germany Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 46. Germany Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 48. France Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 50. U.K. Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 52. Italy Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 54. Russia Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Anti-PD-1 Antibody Market Share by Type in 2019
Figure 56. Europe Anti-PD-1 Antibody Market Share by Application in 2019
Figure 57. Asia Pacific Anti-PD-1 Antibody Sales Growth Rate 2015-2020 (Kg)
Figure 58. Asia Pacific Anti-PD-1 Antibody Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Anti-PD-1 Antibody Sales Market Share by Region in 2019
Figure 60. Asia Pacific Anti-PD-1 Antibody Revenue Market Share by Region in 2019
Figure 61. China Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 62. China Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 64. Japan Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 66. South Korea Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 68. India Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 70. Australia Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 72. Taiwan Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 74. Indonesia Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 76. Thailand Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 78. Malaysia Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 80. Philippines Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 82. Vietnam Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Anti-PD-1 Antibody Market Share by Type in 2019
Figure 84. Asia Pacific Anti-PD-1 Antibody Market Share by Application in 2019
Figure 85. Latin America Anti-PD-1 Antibody Sales Growth Rate 2015-2020 (Kg)
Figure 86. Latin America Anti-PD-1 Antibody Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Anti-PD-1 Antibody Sales Market Share by Country in 2019
Figure 88. Latin America Anti-PD-1 Antibody Revenue Market Share by Country in 2019
Figure 89. Mexico Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 90. Mexico Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 92. Brazil Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 94. Argentina Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Anti-PD-1 Antibody Market Share by Type in 2019
Figure 96. Latin America Anti-PD-1 Antibody Market Share by Application in 2019
Figure 97. Middle East and Africa Anti-PD-1 Antibody Sales Growth Rate 2015-2020 (Kg)
Figure 98. Middle East and Africa Anti-PD-1 Antibody Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Anti-PD-1 Antibody Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Anti-PD-1 Antibody Revenue Market Share by Country in 2019
Figure 101. Turkey Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 102. Turkey Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 104. Saudi Arabia Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 106. U.A.E Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Anti-PD-1 Antibody Market Share by Type in 2019
Figure 108. Middle East and Africa Anti-PD-1 Antibody Market Share by Application in 2019
Figure 109. Bio X Cell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Thermo Fisher Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. InvivoGen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. BioVision Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Abcam Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Bristol-Myers Squibb (BMS) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Ono Pharmaceutical Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Chugai Pharmaceutical Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. BeiGene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Abbvie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. TG Therapeutics, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. Arcus Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 124. Sino Biological Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 125. 3SBio Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 126. North America Anti-PD-1 Antibody Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 127. North America Anti-PD-1 Antibody Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Europe Anti-PD-1 Antibody Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 129. Europe Anti-PD-1 Antibody Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Asia Pacific Anti-PD-1 Antibody Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 131. Asia Pacific Anti-PD-1 Antibody Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 132. Latin America Anti-PD-1 Antibody Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 133. Latin America Anti-PD-1 Antibody Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 134. Middle East and Africa Anti-PD-1 Antibody Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 135. Middle East and Africa Anti-PD-1 Antibody Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 136. Porter's Five Forces Analysis
Figure 137. Channels of Distribution
Figure 138. Distributors Profiles
Figure 139. Bottom-up and Top-down Approaches for This Report
Figure 140. Data Triangulation
Figure 141. Key Executives Interviewed
Figure 1. Anti-PD-1 Antibody Product Picture
Figure 2. Global Anti-PD-1 Antibody Sales Market Share by Type in 2020 & 2026
Figure 3. Monoclonal Product Picture
Figure 4. Polyclonal Product Picture
Figure 5. Global Anti-PD-1 Antibody Sales Market Share by Application in 2020 & 2026
Figure 6. IHC-P
Figure 7. ICC/IF
Figure 8. WB
Figure 9. Flow Cytometry
Figure 10. ELISA
Figure 11. Anti-PD-1 Antibody Report Years Considered
Figure 12. Global Anti-PD-1 Antibody Market Size 2015-2026 (US$ Million)
Figure 13. Global Anti-PD-1 Antibody Sales 2015-2026 (Kg)
Figure 14. Global Anti-PD-1 Antibody Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Anti-PD-1 Antibody Sales Market Share by Region (2015-2020)
Figure 16. Global Anti-PD-1 Antibody Sales Market Share by Region in 2019
Figure 17. Global Anti-PD-1 Antibody Revenue Market Share by Region (2015-2020)
Figure 18. Global Anti-PD-1 Antibody Revenue Market Share by Region in 2019
Figure 19. Global Anti-PD-1 Antibody Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Anti-PD-1 Antibody Revenue in 2019
Figure 21. Anti-PD-1 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Anti-PD-1 Antibody Sales Market Share by Type (2015-2020)
Figure 23. Global Anti-PD-1 Antibody Sales Market Share by Type in 2019
Figure 24. Global Anti-PD-1 Antibody Revenue Market Share by Type (2015-2020)
Figure 25. Global Anti-PD-1 Antibody Revenue Market Share by Type in 2019
Figure 26. Global Anti-PD-1 Antibody Market Share by Price Range (2015-2020)
Figure 27. Global Anti-PD-1 Antibody Sales Market Share by Application (2015-2020)
Figure 28. Global Anti-PD-1 Antibody Sales Market Share by Application in 2019
Figure 29. Global Anti-PD-1 Antibody Revenue Market Share by Application (2015-2020)
Figure 30. Global Anti-PD-1 Antibody Revenue Market Share by Application in 2019
Figure 31. North America Anti-PD-1 Antibody Sales Growth Rate 2015-2020 (Kg)
Figure 32. North America Anti-PD-1 Antibody Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Anti-PD-1 Antibody Sales Market Share by Country in 2019
Figure 34. North America Anti-PD-1 Antibody Revenue Market Share by Country in 2019
Figure 35. U.S. Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 36. U.S. Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 38. Canada Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Anti-PD-1 Antibody Market Share by Type in 2019
Figure 40. North America Anti-PD-1 Antibody Market Share by Application in 2019
Figure 41. Europe Anti-PD-1 Antibody Sales Growth Rate 2015-2020 (Kg)
Figure 42. Europe Anti-PD-1 Antibody Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Anti-PD-1 Antibody Sales Market Share by Country in 2019
Figure 44. Europe Anti-PD-1 Antibody Revenue Market Share by Country in 2019
Figure 45. Germany Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 46. Germany Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 48. France Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 50. U.K. Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 52. Italy Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 54. Russia Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Anti-PD-1 Antibody Market Share by Type in 2019
Figure 56. Europe Anti-PD-1 Antibody Market Share by Application in 2019
Figure 57. Asia Pacific Anti-PD-1 Antibody Sales Growth Rate 2015-2020 (Kg)
Figure 58. Asia Pacific Anti-PD-1 Antibody Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Anti-PD-1 Antibody Sales Market Share by Region in 2019
Figure 60. Asia Pacific Anti-PD-1 Antibody Revenue Market Share by Region in 2019
Figure 61. China Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 62. China Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 64. Japan Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 66. South Korea Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 68. India Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 70. Australia Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 72. Taiwan Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 74. Indonesia Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 76. Thailand Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 78. Malaysia Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 80. Philippines Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 82. Vietnam Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Anti-PD-1 Antibody Market Share by Type in 2019
Figure 84. Asia Pacific Anti-PD-1 Antibody Market Share by Application in 2019
Figure 85. Latin America Anti-PD-1 Antibody Sales Growth Rate 2015-2020 (Kg)
Figure 86. Latin America Anti-PD-1 Antibody Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Anti-PD-1 Antibody Sales Market Share by Country in 2019
Figure 88. Latin America Anti-PD-1 Antibody Revenue Market Share by Country in 2019
Figure 89. Mexico Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 90. Mexico Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 92. Brazil Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 94. Argentina Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Anti-PD-1 Antibody Market Share by Type in 2019
Figure 96. Latin America Anti-PD-1 Antibody Market Share by Application in 2019
Figure 97. Middle East and Africa Anti-PD-1 Antibody Sales Growth Rate 2015-2020 (Kg)
Figure 98. Middle East and Africa Anti-PD-1 Antibody Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Anti-PD-1 Antibody Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Anti-PD-1 Antibody Revenue Market Share by Country in 2019
Figure 101. Turkey Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 102. Turkey Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 104. Saudi Arabia Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg)
Figure 106. U.A.E Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Anti-PD-1 Antibody Market Share by Type in 2019
Figure 108. Middle East and Africa Anti-PD-1 Antibody Market Share by Application in 2019
Figure 109. Bio X Cell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Thermo Fisher Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. InvivoGen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. BioVision Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Abcam Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Bristol-Myers Squibb (BMS) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Ono Pharmaceutical Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Chugai Pharmaceutical Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. BeiGene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Abbvie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. TG Therapeutics, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. Arcus Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 124. Sino Biological Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 125. 3SBio Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 126. North America Anti-PD-1 Antibody Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 127. North America Anti-PD-1 Antibody Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Europe Anti-PD-1 Antibody Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 129. Europe Anti-PD-1 Antibody Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Asia Pacific Anti-PD-1 Antibody Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 131. Asia Pacific Anti-PD-1 Antibody Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 132. Latin America Anti-PD-1 Antibody Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 133. Latin America Anti-PD-1 Antibody Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 134. Middle East and Africa Anti-PD-1 Antibody Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 135. Middle East and Africa Anti-PD-1 Antibody Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 136. Porter's Five Forces Analysis
Figure 137. Channels of Distribution
Figure 138. Distributors Profiles
Figure 139. Bottom-up and Top-down Approaches for This Report
Figure 140. Data Triangulation
Figure 141. Key Executives Interviewed
